Recombinant Human Interleukin-22 (IL22) (Active)
Description
Mechanism of Action
IL-22 signals through JAK-STAT, ERK1/2, and PI3K/AKT pathways, primarily targeting epithelial and stromal cells :
| Pathway | Key Components | Functional Outcome |
|---|---|---|
| JAK-STAT | JAK1, TYK2, STAT3 | Cell survival, proliferation |
| ERK1/2 | MEK, ERK, RSK | Anti-apoptotic signaling |
| PI3K/AKT | PI3K, AKT, GSK3β | Metabolic regulation |
Unlike most cytokines, IL-22 does not directly activate immune cells but enhances epithelial barrier function via:
-
Antimicrobial Peptides: Upregulates β-defensins and RegIII proteins
-
Mucin Production: Induces MUC1, MUC3, and MUC13 in goblet cells
Protective Effects
-
Colitis: In TRUC mice, IL-22 neutralization reduced colitis severity by suppressing Cxcl1 and Cxcl5, critical for neutrophil recruitment .
-
Pancreatitis: Enhances acinar cell survival via Bcl-2 and Bcl-XL upregulation .
-
Infection: Limits Klebsiella pneumoniae lung invasion by boosting antimicrobial defenses .
Pathogenic Potential
-
Autoimmunity: Elevated IL-22 correlates with Crohn’s disease and rheumatoid arthritis .
-
Cancer: Promotes STAT3-driven tumor growth in glioblastoma and liver malignancies .
Key Research Findings
Therapeutic Trials
-
ILV-094: Anti-IL-22 antibody in Phase II trials for psoriasis (NCT01010542) .
-
F-652 (IL-22-Fc dimer): Phase IIa trial for alcoholic hepatitis showed increased acute-phase proteins without systemic inflammation .
Challenges and Future Directions
While IL-22 promotes epithelial repair, its dual role in inflammation and cancer necessitates precise targeting. Strategies under exploration include:
Product Specs
Target Background
- These findings demonstrate that CD147 serves as a novel and crucial mediator in IL-22-induced psoriatic alterations within the epidermis. This suggests that CD147 might be a potential therapeutic target for patients with psoriasis. PMID: 28272440
- Our research indicates that variants of the IL22 gene may significantly contribute to the pathogenesis of Cerebral Malaria (CM). These IL22 variants are associated with increased severity of malaria. Notably, the rs2227473 risk allele (T allele) is linked to elevated IL-22 production, implying a role for IL-22 in the development of CM. PMID: 28139719
- This study sheds light on a mechanism by which the IL-22 pathway empowers the human intestinal epithelium to effectively control microbial infections. PMID: 30217896
- The rs1179251 polymorphism has been identified as a potential risk factor for cancer based on a meta-analysis. PMID: 29761647
- Our findings indicate that the expression of miR-548a-3p is upregulated in keratinocyte proliferative disorders like psoriasis, which are often mediated by IL-22. PMID: 29181737
- IL-22 is involved in the resistance of A549 cells to paclitaxel by regulating cell apoptosis through the JNK signaling pathway. PMID: 29723165
- This review summarizes the current understanding of IL-22's diverse roles in various pancreatic pathologies, providing insights into the underlying cellular and signaling mechanisms. PMID: 29502986
- IL22 expression is upregulated by atorvastatin, losartan, and captopril. Polymorphisms in the IL22 gene may play a role in hypertension and coronary artery disease. PMID: 29981321
- Elevated urinary levels of IL-22 were not found to be associated with Candida urinary tract infections. PMID: 29421775
- The expression of the lncRNA H19 is increased in inflamed intestinal tissues from both mice and human patients. The inflammatory cytokine IL22 induces the expression of H19 in intestinal epithelial cells (IECs), which is essential for IEC proliferation and mucosal healing. Mechanistically, H19 lncRNA appears to inhibit p53 protein and microRNAs 34a and let-7, ultimately promoting IEC proliferation and epithelial regeneration. PMID: 29621481
- Keratinocytes in hidradenitis suppurativa exhibited reduced amounts of IL-22. PMID: 28972431
- In a study of Chinese subjects, plasma concentrations of interleukin-22 (IL-22) were found to be strongly associated with susceptibility to impaired fasting glucose (IFG) and type 2 diabetes. Notably, decreased plasma IL-22 levels emerged as a potential trigger for IFG and type 2 diabetes. PMID: 28170163
- IL-22's effect on intestinal epithelial cell responses might not be solely through the induction of CXCL8. Instead, IL-22 may enhance TNF-alpha- and IL-1-induced CXCL8 secretion, amplifying the contribution of IECs to local inflammatory responses. PMID: 28656529
- Despite the presence of all Notch pathway molecules in the kidney and model-specific induction of Notch ligands, IL-22 was upregulated only in acute inflammation but rapidly downregulated during regeneration. This observation suggests that when targeting injury responses, such as via IL-22, species-specific differences, injury type, and time points must be carefully considered. PMID: 29054964
- Our findings suggest that IL-22 plays diverse roles in tuberculosis immune responses. Specifically, membrane-bound IL-22+ T cells may play significant roles in the human immune response to Mycobacterium. PMID: 29050778
- This study demonstrates the immunoregulatory function of lacrimal glands-derived IL-22 in inhibiting IL-17-mediated ocular surface epitheliopathy in dry eye disease. PMID: 28051088
- Serum IL-9 and IL-22 levels are associated with eosinophilia in cow's milk allergy. These two cytokines significantly decrease upon elimination of cow's milk from the diet. PMID: 28934137
- Tracheal aspirates from patients infected with P. aeruginosa contain protease IV activity, which leads to IL-22 degradation. This previously undescribed cleavage of IL-22 by a bacterial protease is likely an immune-evasion strategy employed by P. aeruginosa to contribute to respiratory infections. PMID: 27792459
- This research demonstrates that copy number variations in the IL-22 gene are associated with ankylosing spondylitis in the Chinese Han population. PMID: 28716697
- IL-22 contributes to the inhibition of pulmonary microvascular endothelial cell apoptosis mediated by AngII through activation of the JAK2/STAT3 signaling pathway. PMID: 28827891
- These findings provide a novel perspective on the pro-inflammatory cytokine interleukin-22, revealing its role in promoting aerobic glycolysis associated with tumor progression in human colon cancer cells. PMID: 28445985
- Our findings suggest that IL-22 might have therapeutic potential for the treatment of diabetic nephropathy (DN). IL-22 exerts beneficial effects on DN by simultaneously alleviating systemic metabolic syndrome and downregulating the renal NLRP3/caspase-1/IL-1beta pathway. PMID: 28726774
- Our research indicated that IL-22 -429C/T gene polymorphisms may be associated with colon cancer. PMID: 28624523
- The authors observed that SOCS3 and SOCS1 expression was reduced in vivo in tumor lesions of basal cell carcinoma (BCC) and squamous cell carcinoma (SCC), as compared to other skin inflammatory conditions like psoriasis, despite the high number of IL-22-secreting tumor-infiltrating lymphocytes (TILs). PMID: 28445952
- miR-330 inhibits IL-22-induced proliferation of HaCaT and HKC cells by targeting CTNNB1. PMID: 28501007
- IL-22 protects against sodium nitroprusside-induced apoptosis in rheumatoid arthritis fibroblast-like synoviocytes by activating the STAT3 pathway and its downstream target gene, Bcl-2. PMID: 27493089
- IL22 plays a crucial role in maintaining barrier homeostasis against intestinal pathogens and commensal bacteria. As a member of the IL10 superfamily, it is critically involved in inflammation. [Review] PMID: 29037907
- TARC production in HaCaT keratinocytes through the interaction between IL-22 and IL-22Ralpha facilitates T-cell migration in atopic dermatitis caused by house dust mites. PMID: 26914146
- IL-22 levels were found to be higher in primary progressive multiple sclerosis (PPMS) compared to progressive relapsing multiple sclerosis (PPMS) (p<0.05). PMID: 27344023
- IL-22 is elevated in patients with giant cell arteritis (GCA) and impacts the viability and gene expression of arterial cells, suggesting a potential role in disease pathogenesis. PMID: 28968695
- Our findings suggest that the human IL-22BP isoforms have distinct spatial and temporal roles and collaboratively fine-tune IL-22-dependent STAT3 responses in tissues, acting as a type of rheostat. PMID: 27678220
- IL-18 cooperates with IL-15 to promote group 3 innate lymphoid cell (ILC3) proliferation and IL-22 production. We describe an IL-18-induced, NF-kappaB-mediated mechanism that regulates IL-22 in ILC3s. Under steady-state conditions, IL-18 produced by dendritic cells mediates IL-22 production by ILC3s, contributing to the maintenance of normal tissue integrity. PMID: 28842466
- Our results reveal that IL-22 increases intestinal epithelial permeability by upregulating Claudin-2 expression through the JAK/STAT pathway. PMID: 28939759
- High serum levels of IL-22 were positively associated with several cardiometabolic risk factors, rather than inversely. However, these associations did not translate into an increased risk for type 2 diabetes. PMID: 28143481
- Mucosal-associated invariant T cells in the genital mucosa exhibit a distinct IL-17/IL-22 profile and may play a crucial role in the immunological homeostasis and control of microbes at this site. PMID: 27049062
- Our findings indicate that disease lavage IL-22 concentrations are highest in patients with pneumonia and lung cancer and do not significantly correlate with systemic inflammation. PMID: 27388918
- Increased expression of IL-22Ralpha promotes keratinocyte proliferation and pro-inflammatory cytokine production during UVB-induced skin inflammation. This suggests that UVB facilitates skin inflammation by enhancing the responsiveness of keratinocytes to IL-22. PMID: 28558005
- In conclusion, Notch signaling appears to be an important mediator of liver inflammation by modulating hepatic IL-22-secreting NKp46(+) innate lymphoid cells. PMID: 27800305
- High levels of IL-22 are associated with Lyme disease. PMID: 27101991
- Keratinocytes release IL-23 in response to endogenous TLR4 ligands. This IL-23 specifically targets skin dendritic cells expressing IL-23R, inducing them to upregulate their endogenous IL-23 production. This, in turn, drives an IL-22 response in naive CD4(+) T cells, ultimately mediating epidermal thickening. PMID: 27551155
- Patients with type 2 diabetes mellitus (T2DM) and coronary artery disease (CAD) exhibit increased serum IL-22 levels. Elevated serum IL-22 is associated with the incidence of CAD and T2DM. However, further in vitro studies established the protective role of IL-22 against endothelial dysfunction, a critical process involved in the early development of atherosclerosis and vascular complications in T2DM. IL-22 may exert different functions under varying contexts. PMID: 27829708
- Plasma levels of IL-22 are highly elevated after major liver resection. PMID: 26853442
- IL-22 and its receptor play a crucial role in the development and pathogenesis of uveitis by facilitating inflammatory cell infiltration. PMID: 27166675
- No association was found between IL-22 single nucleotide polymorphisms (SNPs) (rs2227485, rs2272478, rs2227491) and the development of ulcerative colitis in a Mexican population. PMID: 26994530
- The mutual benefit gained from interactions between the host and commensal intestinal bacteria-derived factors is an expanding field of research with growing clinical implications. The data presented here suggest a supportive and fine-tuning role for butyrate in IL-22 signaling, which could potentially be exploited therapeutically by administering butyrate locally. PMID: 27801948
- This study demonstrates that human gammadelta T cell-antigen-presenting cells stimulate CD4+ T cell responses distinct from those induced by myeloid antigen-presenting cells. This distinct stimulation promotes local barrier defense through mucosal release of IL-22 and calprotectin. PMID: 28330898
- A significant direct correlation was observed between IL-10 and IL-22 levels in the patient group (p=0.0005). The clinical severity of psoriasis was significantly correlated with high IL-22 levels (p<0.0001). PMID: 27999243
- IL-22 mRNA levels in middle ear effusion from otitis media with effusion patients were higher in those with sinusitis than without. Furthermore, IL-22 expression was significantly higher in mucoid and purulent middle ear fluid samples compared to serous fluid samples. PMID: 27729129
- IL-22 plays pathological roles in the development of recurrent hepatitis C after liver transplantation. PMID: 27123854
- The results suggest that IL-22 production in blood may act as a pathogenic factor in HIV infection. PMID: 25556046
Q&A
What is the molecular structure of human IL-22 and how does it differ from other IL-10 family cytokines?
Human IL-22 is a cytokine belonging to the IL-10 family with a crystallographic structure solved at 2.0 Å resolution. Unlike IL-10, which functions as a homodimer with interpenetrating secondary structures, IL-22 forms dimers through interface interactions between monomers. This structural difference is functionally significant as IL-22 most likely interacts with its receptor as a monomer, whereas IL-10 requires a homodimeric form for signaling . The active recombinant human IL-22 protein typically encompasses amino acids Ala34-Ile179 of the full sequence and appears as bands at 28-32 kDa when resolved with SDS-PAGE under both reducing and non-reducing conditions .
What are the primary signaling pathways activated by IL-22?
IL-22 primarily activates signal transducers and activators of transcription (STAT) factors 1 and 3, as well as acute phase reactants in hepatoma cell lines, suggesting its involvement in inflammatory responses . When binding to its receptor complex, IL-22 triggers phosphorylation of STAT3, which serves as a key downstream signaling mediator . This activation pathway is essential for IL-22's biological functions, including regulation of epithelial cell proliferation, differentiation, and survival. Researchers can verify IL-22 signaling activity by measuring STAT3 phosphorylation via western blot or related techniques.
How can researchers verify the biological activity of recombinant human IL-22?
The biological activity of recombinant human IL-22 can be assessed through its ability to induce IL-10 secretion in COLO 205 human colorectal adenocarcinoma cells. The effective dose that induces 50% of maximum response (ED50) typically ranges from 0.160 to 1.60 ng/mL . This standardized assay provides a reliable method for confirming that recombinant IL-22 is functionally active. Additionally, researchers can measure STAT3 phosphorylation in target cells as a direct indicator of IL-22 signaling activity. Neutralizing antibodies against IL-22 can be used as controls to confirm that observed effects are specifically IL-22-dependent .
What are the optimal concentration ranges for IL-22 in different experimental systems?
Based on available research, IL-22 concentration requirements vary significantly depending on the experimental model and desired outcome. In ileal organoid models, concentrations as low as 100 pmol/L can induce significant effects on organoid size and survival . At this concentration, IL-22 causes organoids to grow approximately three times larger than controls while simultaneously decreasing organoid survival by about 28%. Higher concentrations (500 pmol/L) produce more pronounced effects on both growth and survival .
It is critical to note that physiologically relevant IL-22 concentrations likely differ between systemic circulation and local tissue microenvironments. Computational modeling suggests that IL-22 concentrations in the intestinal stem cell (ISC) microenvironment may be substantially different from those measured in serum samples from patients . Therefore, researchers should consider the following concentration guidelines:
| Experimental System | Recommended IL-22 Concentration Range | Expected Outcomes |
|---|---|---|
| Cell Lines (in vitro) | 0.16-1.60 ng/mL | IL-10 induction in COLO 205 cells |
| Organoid Models | 100-500 pmol/L | Increased growth with decreased survival |
| Microenvironment Models | Computationally modeled based on distance from IL-22-producing cells | More physiologically relevant responses |
What methodological approaches are most effective for studying IL-22's effects on epithelial stem cells?
When investigating IL-22's impact on epithelial stem cells, organoid models offer significant advantages. Researchers should consider the following methodological approach:
-
Establish ileal crypts in vitro for initial culture establishment
-
Supplement with varying concentrations of IL-22 (typically 100-500 pmol/L)
-
Evaluate multiple parameters including:
To establish causality, include appropriate controls such as neutralizing antibodies against IL-22, which block IL-22-dependent STAT3 phosphorylation and reverse the IL-22-induced phenotypic changes . This confirms that observed effects are specifically IL-22-dependent rather than resulting from experimental artifacts or other factors.
How can researchers accurately model IL-22 concentrations in tissue microenvironments?
While direct measurement of IL-22 levels in the microenvironment remains technically challenging, computational modeling provides a valuable alternative. Using tools such as COMSOL Multiphysics, researchers can predict IL-22 concentrations in specific microenvironments, such as the intestinal stem cell niche .
The modeling approach should consider:
-
The distance between IL-22-producing cells (e.g., ILC3s) and target cells
-
The number of IL-22-producing cells in the defined space
-
Diffusion properties of the tissue
-
Receptor-mediated uptake and degradation of IL-22
This computational approach allows researchers to approximate microenvironment concentrations in three-dimensional space, providing more physiologically relevant estimates than those obtained from serum measurements . These models help bridge the gap between in vitro experimental conditions and the actual concentrations experienced by cells in vivo.
What are the emerging research areas for IL-22 as identified through bibliometric analysis?
Bibliometric analysis of IL-22 research from 2014 to 2023 reveals several emerging high-potential research areas. The involvement of IL-22 in microbial populations and cancer cell spread has been identified as having strong research potential and currently represents a hot research topic . High-frequency keywords in IL-22 research involve molecular biology (particularly IL-17) and immune response (T cells, specifically Th17 cells) as well as various diseases (autoimmune diseases and cancer) .
From January 2014 to December 2023, 25,134 authors from 4,206 institutions in 106 countries published 3,943 articles on IL-22 research in 940 academic journals, with steadily increasing publication numbers over this period . The United States and China are the primary contributors to this research field, with the most active institutions being the Medical Research Institute (INSERM) and the University of California system .
How can single-cell RNA sequencing enhance our understanding of IL-22 receptor expression patterns?
Single-cell RNA sequencing (scRNA-seq) represents a powerful approach for dissecting the heterogeneity of IL-22 receptor expression across different cell populations. This technique has been successfully employed to assess IL22ra1 expression patterns in intestinal stem cells (ISCs) and transit-amplifying (TA) progenitors .
The methodological workflow for such studies typically involves:
-
Isolation of target cell populations from relevant tissues
-
Generation of single-cell suspensions
-
Library preparation and sequencing
-
Computational analysis to identify cell clusters and expression patterns
-
Validation of findings through orthogonal methods
This approach provides unprecedented resolution of receptor expression patterns, enabling researchers to identify specific cell subpopulations that respond to IL-22. Understanding these expression patterns is crucial for interpreting the cell type-specific effects of IL-22 in complex tissues and may reveal previously unrecognized target populations for IL-22-based therapies.
What are the current approaches for studying IL-22's role in disease pathogenesis?
Multiple complementary approaches are employed to investigate IL-22's role in disease pathogenesis:
-
Organoid Models: Organoids derived from primary tissues provide a physiologically relevant system for studying IL-22's effects on epithelial cells. These models allow for detailed investigation of how IL-22 affects stem cell function, proliferation, differentiation, and survival .
-
Transgenic Mouse Models: IL-22-transgenic mice serve as valuable tools to confirm the impact of increased IL-22 on proliferative cells in vivo . These models enable researchers to study the long-term consequences of altered IL-22 signaling in complex tissue environments.
-
Computational Modeling: Predicting microenvironment levels of IL-22 guides more physiologically relevant dose-response experiments in vitro and provides more accurate interpretations of IL-22's mechanisms of action .
-
Bibliometric Analysis: Systematic review of publication trends helps identify emerging research directions and potential therapeutic applications of IL-22 .
How can researchers distinguish between direct and indirect effects of IL-22 on target cells?
Distinguishing direct from indirect IL-22 effects requires a systematic approach:
-
Receptor Expression Analysis: Confirm IL-22 receptor expression on target cells using techniques such as qRT-PCR, flow cytometry, or single-cell RNA sequencing .
-
Pathway Inhibition Studies: Use specific inhibitors of STAT3 phosphorylation or other downstream mediators to block direct IL-22 signaling.
-
Conditional Knockout Models: Generate cell type-specific receptor knockouts to eliminate direct IL-22 signaling in specific populations.
-
Neutralizing Antibodies: Apply IL-22 neutralizing antibodies to confirm that observed phenotypes are specifically IL-22-dependent .
-
Isolated Cell Systems: Test IL-22 effects on purified cell populations to eliminate paracrine effects from other cell types.
This multi-faceted approach allows researchers to confidently attribute observed phenotypes to direct IL-22 signaling rather than secondary effects mediated by other factors or cell types.
What are the limitations of current methods for studying IL-22 in complex tissue environments?
Current methodological limitations include:
-
Concentration Measurement: Direct measurement of IL-22 concentrations in tissue microenvironments remains technically challenging, necessitating computational modeling approaches .
-
Receptor Complex Dynamics: Understanding the dynamic assembly and signaling of the IL-22 receptor complex in native contexts requires advanced imaging techniques not widely available.
-
Redundancy with Related Cytokines: Distinguishing IL-22-specific effects from those of related cytokines requires careful experimental design with appropriate controls.
-
Translating In Vitro Findings: Bridging the gap between in vitro observations and in vivo relevance remains challenging, particularly regarding concentration-dependent effects.
Researchers can address these limitations through integrated approaches combining computational modeling, advanced imaging techniques, genetic models, and careful control experiments to validate findings across multiple experimental systems.
What are the promising therapeutic applications of IL-22 based on current research?
Current research suggests several promising therapeutic applications for IL-22:
-
Immunotherapy: Breakthrough progress is being made in immunotherapy research, with IL-22 emerging as a potential therapeutic target .
-
Autoimmune Diseases: Given IL-22's role in inflammatory processes, modulating its activity might provide therapeutic benefits in various autoimmune conditions .
-
Cancer: IL-22's involvement in cancer cell spread suggests potential anti-cancer applications through targeted inhibition of IL-22 signaling .
-
Tissue Regeneration: IL-22's effects on epithelial proliferation and differentiation indicate potential applications in promoting tissue repair and regeneration .
In-depth study of IL-22 and its signal transduction mechanisms remains crucial for understanding its biological functions and developing effective therapeutic strategies .
How might advanced computational approaches enhance our understanding of IL-22 biology?
Advanced computational approaches offer significant potential for advancing IL-22 research:
-
Microenvironment Modeling: Further refinement of computational models to predict IL-22 concentrations in specific tissue microenvironments will enable more physiologically relevant experimental designs .
-
Systems Biology Approaches: Integration of multiple datasets (transcriptomic, proteomic, epigenetic) can provide comprehensive views of IL-22's effects across different cellular contexts.
-
Network Analysis: Identifying interaction networks between IL-22 and other cytokines or signaling pathways may reveal synergistic or antagonistic relationships relevant to disease states.
-
Machine Learning Applications: Pattern recognition in large datasets may identify previously unrecognized associations between IL-22 signaling and specific disease phenotypes.
These computational approaches, combined with experimental validation, will likely drive significant advances in our understanding of IL-22 biology and its therapeutic applications.
